Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Uranium Energy Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while Uranium Energy Corp trades at $7.55 (market cap $3.82B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 8.1× Uranium Energy Corp's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals.
| GEHC | UEC | |
|---|---|---|
Market Cap | $30.93B | $3.82B |
Volume | 5,033,451 | 13,882,337 |
Sector | Health | Energy |
52-Week High | $88.16 | $20.14 |
52-Week Low | $59.48 | $7.70 |
Enterprise Value | $39.39B | $3.32B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Uranium Energy (UEC) trades at $8.25, down 6.57% today, amid bearish technical signals despite strong analyst support. The company shows mixed fundamentals with revenue of $66.84M in 2025 but significant losses (-$87.66M net income), while expanding production capacity with two operational mines. Recent news highlights operational improvements and growing U.S. government demand for domestic uranium.
Outlook remains speculative with high execution risk; while analyst consensus is bullish (87.5% buy ratings, $16.06 target), persistent negative margins and cash burn require careful monitoring. Investment opportunity hinges on successful production scaling and uranium price sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
